The EACPT Pharmacovigilance Working Group aims to establish a European forum for clinical pharmacovigilance, focusing on the detection, assessment, prevention and management of adverse drug reactions in real-world clinical practice.
The group will promote hospital-based pharmacovigilance, active surveillance, case-based ADR discussions, real-world data methods, patient-centred safety, education and collaborative research. It will bring together recognised European experts, pharmacovigilance centres, clinical pharmacologists, healthcare professionals and early-career members to foster shared learning, mentorship and multicentre collaboration.
The Working Group will act as the clinical and academic counterpart to regulatory pharmacovigilance within EACPT, working in close connection with the Regulatory Working Group to ensure that regulatory safety knowledge is translated into clinical implementation, bedside assessment, risk minimisation and improved patient care.
Objectives of the Working Group
Promote Clinical Pharmacovigilance
Strengthen the role of clinical pharmacology in the detection, assessment and prevention of adverse drug reactions in real-world practice.
Support Hospital-Based Safety Programmes
Encourage active pharmacovigilance in hospitals and clinical settings, including structured ADR detection, spontaneous reporting and clinical causality assessment.
Advance Methodological Innovation
Promote the use of real-world data, safety signals, disproportionality analyses and active surveillance methods to improve medicine safety.
Foster Education and Training
Increase the visibility of practical pharmacovigilance in EACPT congresses, webinars and educational activities.
Build a European Network
Connect clinical pharmacologists, healthcare professionals, researchers and early-career members interested in pharmacovigilance and medicine safety.
Collaborate Across Disciplines
Develop synergies with other EACPT Working Groups and relevant scientific societies to support safer and more effective use of medicines.
Areas of Interest
- Hospital pharmacovigilance and spontaneous reporting
- Regional pharmacovigilance centres
- Safety signals and signal validation
- Disproportionality studies
- Active pharmacovigilance
- Pharmacogenetics and pharmacovigilance
- Vaccine safety and reactogenicity
- Immunovigilance in clinical practice
- Patient-centred safety monitoring
Interested in joining?
We welcome EACPT members from all countries and career stages. If you are interested in adverse drug reactions, medicine safety, real-world data, hospital pharmacovigilance or patient-centred approaches to safer prescribing, we would be happy to hear from you.